These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31007494)

  • 1. A rare case of cefepime-induced cholestatic liver injury.
    Liao PF; Wu YK; Huang KL; Chen HY
    Ci Ji Yi Xue Za Zhi; 2019; 31(2):124-128. PubMed ID: 31007494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case-Report of Drug-Induced Mixed Liver Injury Resulting From Cefepime Exposure.
    Malhotra K; Fazylov R; Friedman-Jakubovics M
    J Pharm Pract; 2023 Feb; 36(1):164-167. PubMed ID: 34098807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Carbamazepine-induced Severe Cholestatic Hepatitis: Case Report and Review of Literature.
    Ganesh S; Shukla L; Kandasamy A; Benegal V
    Indian J Psychol Med; 2017; 39(5):688-690. PubMed ID: 29200572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A challenge for diagnosing acute liver injury with concomitant/sequential exposure to multiple drugs: can causality assessment scales be utilized to identify the offending drug?
    Lim R; Choudry H; Conner K; Karnsakul W
    Case Rep Pediatr; 2014; 2014():156389. PubMed ID: 25506455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and pathological features in 138 cases of drug-induced liver injury].
    Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced liver injury.
    Abboud G; Kaplowitz N
    Drug Saf; 2007; 30(4):277-94. PubMed ID: 17408305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection.
    Carrascosa MF; Lucena MI; Andrade RJ; Caviedes JR; Lavín AC; Mones JC; Rivero AP; Serrano VB
    Clin Ther; 2009 May; 31(5):1014-9. PubMed ID: 19539102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cephalexin induced cholestatic jaundice.
    Agrawal A; Rao M; Jasdanwala S; Mathur A; Eng M
    Case Rep Gastrointest Med; 2014; 2014():260743. PubMed ID: 25180107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thioctic acid-induced acute cholestatic hepatitis.
    Ridruejo E; Castiglioni T; Silva MO
    Ann Pharmacother; 2011 Jul; 45(7-8):e43. PubMed ID: 21672886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydralazine-induced cholestatic hepatitis.
    Hassan A; Hammad R; Cucco R; Niranjan S
    Am J Ther; 2009; 16(4):371-3. PubMed ID: 19092641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Danger of Herbal Tea: A Case of Acute Cholestatic Hepatitis Due to
    Ruperti-Repilado FJ; Haefliger S; Rehm S; Zweier M; Rentsch KM; Blum J; Jetter A; Heim M; Leuppi-Taegtmeyer A; Terracciano L; Bernsmeier C
    Front Med (Lausanne); 2019; 6():221. PubMed ID: 31681778
    [No Abstract]   [Full Text] [Related]  

  • 12. Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection.
    Paredes AH; Lewis JH
    Ann Pharmacother; 2007 May; 41(5):880-4. PubMed ID: 17426078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memantine-Induced Liver Injury With Probable Causality as Assessed Using the Roussel Uclaf Causality Assessment Method (RUCAM).
    Shumar J; Ordway S; Junga Z; Sadowski B; Torres D
    ACG Case Rep J; 2019 Aug; 6(8):e00184. PubMed ID: 31737715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent cholestasis due to ampicillin.
    Köklü S; Yüksel O; Filik L; Usküdar O; Altundag K; Altiparmak E
    Ann Pharmacother; 2003 Mar; 37(3):395-7. PubMed ID: 12639171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin-induced Liver Injury Patterns: A Clinical Review.
    Averbukh LD; Turshudzhyan A; Wu DC; Wu GY
    J Clin Transl Hepatol; 2022 Jun; 10(3):543-552. PubMed ID: 35836753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinic-epidemiological significance of drug hepatotoxicity in liver disease consultation].
    Jmelnitzky AC; Guidi M; Bologna A; Viola M; Soccini C; Barbero R; Belloni P; Apraiz M
    Acta Gastroenterol Latinoam; 2000; 30(2):77-84. PubMed ID: 10925723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.
    García-Cortés M; Lucena MI; Pachkoria K; Borraz Y; Hidalgo R; Andrade RJ;
    Aliment Pharmacol Ther; 2008 May; 27(9):780-9. PubMed ID: 18284654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.
    Xie W; Wang Q; Gao Y; Pan CQ
    BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hepatitis associated with the use of levofloxacin.
    Figueira-Coelho J; Pereira O; Picado B; Mendonça P; Neves-Costa J; Neta J
    Clin Ther; 2010 Sep; 32(10):1733-7. PubMed ID: 21194596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albendazole Induced Recurrent Acute Toxic Hepatitis: A Case Report.
    Bilgic Y; Yilmaz C; Cagin YF; Atayan Y; Karadag N; Harputluoglu MMM
    Acta Gastroenterol Belg; 2017; 80(2):309-311. PubMed ID: 29560698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.